Delivery Order SPE2DB22D3501-SPE2DB25FXL02
- Not listed
- The Defense Logistics Agency awarded a $2,357.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Xcopri 25 mg tablets (30-count). This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 6, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract involves no set-aside designation and identifies Conshohocken, Pennsylvania, as the place of performance,...
- The Defense Logistics Agency awarded a $3,017.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 200 mg tablets (30-count units). The award is non-competitive with no set-aside designation and carries an ultimate completion date of August 18, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,474.73 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xcopri 25 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 16, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count units). This contract was competitively awarded on July 23, 2025, with a firm fixed price structure and an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,413.60 on August 25, 2025, for the supply of Xcopri 200 mg tablets (30-count). The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and represents a non-competitive set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) valued at $1,037.97. This firm fixed-price delivery order, with an ultimate completion date of August 18, 2025, represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xcopri 150 mg tablets (30-count units) under a firm fixed price contract valued at $1,393.98. This non-set-aside, competitively awarded delivery order has an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item procurement of this neurological...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.86 to AmerisourceBergen Drug Corp for 30 tablets of Xcopri 200 mg, with an ultimate completion date of August 13, 2025. This competitive award, issued on August 12, 2025, employs firm fixed pricing and carries no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1.77K to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Xcopri 100 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Xcopri 100 mg tablets (30-count packaging) with a ceiling value of $1,178.96. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order will be fulfilled from the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXL02Delivery Order
The Defense Logistics Agency awarded a $2,516.81 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Xcopri 200 mg tablets (30 count). This competitively awarded, non-set-aside contract with firm fixed pricing is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving customers such as the Defense Health Agency and U.S. Coast Guard. The award demonstrates the contractor's continued capability to fulfill federal medical supply requirements for specialty medications across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/19/25 |